Livmarli |
Human |
Maralixibat chloride |
Maralixibat chloride |
EMEA/H/C/005857 |
Mirum Pharmaceuticals International B.V. |
2022/12/09
|
Authorised |
Spevigo |
Human |
spesolimab |
Spesolimab |
EMEA/H/C/005874 |
Boehringer Ingelheim International GmbH |
2022/12/09
|
Authorised |
Pemetrexed Baxter |
Human |
pemetrexed |
pemetrexed disodium heptahydrate |
EMEA/H/C/005848 |
Baxter Holding B.V. |
2022/12/09
|
Authorised |
Pluvicto |
Human |
lutetium (177Lu) vipivotide tetraxetan |
lutetium (177Lu) vipivotide tetraxetan |
EMEA/H/C/005483 |
Novartis Europharm Limited |
2022/12/09
|
Authorised |
Locametz |
Human |
gozetotide |
gozetotide |
EMEA/H/C/005488 |
Novartis Europharm Limited |
2022/12/09
|
Authorised |
Qdenga |
Human |
dengue tetravalent vaccine (live, attenuated) |
Dengue virus, serotype 2, expressing Dengue virus, serotype 1, surface proteins, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 3, surface proteins, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, seroty |
EMEA/H/C/005155 |
Takeda GmbH |
2022/12/05
|
Authorised |
Mycapssa |
Human |
octreotide |
Octreotide acetate |
EMEA/H/C/005826 |
Amryt Pharmaceuticals DAC |
2022/12/02
|
Authorised |
Teriparatide Sun |
Human |
teriparatide |
teriparatide |
EMEA/H/C/005793 |
Sun Pharmaceutical Industries Europe B.V. |
2022/11/18
|
Authorised |
Enjaymo |
Human |
sutimlimab |
sutimlimab |
EMEA/H/C/005776 |
Sanofi B.V. |
2022/11/15
|
Authorised |
VidPrevtyn Beta |
Human |
COVID-19 Vaccine (recombinant, adjuvanted) |
SARS-CoV-2 prefusion Spike delta TM protein, recombinant (B.1.351 strain) |
EMEA/H/C/005754 |
Sanofi Pasteur |
2022/11/10
|
Authorised |
Teriflunomide Mylan |
Human |
teriflunomide |
Teriflunomide |
EMEA/H/C/005962 |
Mylan Pharmaceuticals Limited |
2022/11/09
|
Authorised |
Livtencity |
Human |
maribavir |
Maribavir |
EMEA/H/C/005787 |
Takeda Pharmaceuticals International AG Ireland Branch |
2022/11/09
|
Authorised |
Pyrukynd |
Human |
mitapivat |
mitapivat sulfate |
EMEA/H/C/005540 |
Agios Netherlands B.V. |
2022/11/09
|
Authorised |
Sorafenib Accord |
Human |
sorafenib |
Sorafenib tosilate |
EMEA/H/C/005921 |
Accord Healthcare S.L.U. |
2022/11/09
|
Authorised |
Ximluci |
Human |
ranibizumab |
ranibizumab |
EMEA/H/C/005617 |
STADA Arzneimittel AG |
2022/11/09
|
Authorised |
Teriflunomide Accord |
Human |
teriflunomide |
Teriflunomide |
EMEA/H/C/005960 |
Accord Healthcare S.L.U. |
2022/11/09
|
Authorised |
Melatonin Neurim |
Human |
melatonin |
melatonin |
EMEA/H/C/005603 |
RAD Neurim Pharmaceuticals EEC SARL |
2022/11/07
|
Authorised |
Beyfortus |
Human |
nirsevimab |
nirsevimab |
EMEA/H/C/005304 |
AstraZeneca AB |
2022/10/31
|
Authorised |
Tezspire |
Human |
tezepelumab |
tezepelumab |
EMEA/H/C/005588 |
AstraZeneca AB |
2022/09/19
|
Authorised |
Thalidomide Lipomed |
Human |
thalidomide |
Thalidomide |
EMEA/H/C/005715 |
Lipomed GmbH |
2022/09/19
|
Authorised |